Background Compared with HLA-matched sibling donor (MSD) transplant, the outcomes of
haploidentical donor (HID) transplant for refractory acute leukemia need to be further …

This study aimed to investigate graft-versus-leukemia (GVL) of haploidentical donor (HID)
compared with HLA-matched sibling donor (MSD) for high-risk acute myeloid leukemia (H …

The outcomes of an historic comparison of 117 consecutive, high-risk, acute leukemia
patients undergoing hematopoietic stem cell transplantation (HSCT) from HLA-mismatched …

Haploidentical Transplantation Without In Vitro T-Cell Deple... : Medicine Haploidentical
Transplantation Without In Vitro T-Cell Depletion Results in Outcomes Equivalent to Those of …

HLA-haploidentical hematopoietic cell transplantation (Haplo-HCT) using
posttransplantation cyclophosphamide (PT-Cy) has improved donor availability. However, a …

Prior studies have suggested that for leukemia patients with high-risk features, haplo-
identical-hematopoietic stem cell transplantation (HID-HSCT) has a stronger anti-leukemia …

Background In the absence of a HLA-matched related or matched unrelated donor,
allogeneic stem cell transplantation (allo-SCT) from mismatched unrelated donors or …

The effects of HLA-identical sibling donor (ISD) hematopoietic stem cell transplantation
(HSCT) on adults with intermediate-or high-risk acute myeloid leukemia (AML) in the first …

Background Myeloablative (MAC) and reduced-intensity conditioning (RIC) are established
approaches for allogeneic stem cell transplantation (SCT) in acute myeloid leukemia (AML) …

Abstract Reduced‐intensity conditioning (RIC)‐allo SCT is increasingly used for acute
myelogenous leukemia. Limited data are available for the comparison of peripheral blood …